SEC Form 4 · accession 0001553350-15-001332
Entia Biosciences, Inc. · ERGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
ANKA CAPITAL LTD
10% Owner
Period of report
May 8, 2015
Accepted (ET)
Dec 9, 2015 · 12:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001408299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 8, 2015 | A | 2,050,923 | $0.01 | A | 3,042,455 | I | By Delta Group Investments Limited |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were issued upon the cashless exercise of two warrants, 1,700,611 shares were issued upon exercise of a warrant to purchase 1,790,117 shares and 350,312 shares were issued upon exercise of a warrant to purchase 368,750 shares.